You are here: Home:  CCU 3 | 2005: Editor's Office


Editor
Neil Love, MD

Associate Editors
Michelle Paley, MD
Richard Kaderman, PhD

Writers
Lilliam Sklaver Poltorack, PharmD
Sally Bogert, RNC, WHCNP
Douglas Paley
Kathryn Ault Ziel, PhD

CME Director
Michelle Paley, MD

Content Validation and CME Coordinator

Margaret Peng

Art Director
Tamara Dabney

Senior Designer
Christina Brigham

Graphic Designers
Ben Belin
Maria Schaefer

Production Editor
Aura Herrmann

Associate Production Editor
Alexis Oneca

Copy Editors
Sandy Allen
Joy Davis
Pat Morrissey/Havlin

Cirri Nottage

Audio Production
Frank Cesarano

Technical Services
Arly Ledezma

Web Design
John Ribeiro

Production Coordinator
Cheryl Dominguez

Editorial Assistants
Patricia McWhorter
Raquel Segura
Tere Sosa
Ginelle Suarez

Arlene Thorstensen

Contact Information:
Neil Love, MD

Fax: (305) 377-9998
Email:
nlove@researchtopractice.net

Research To Practice
One Biscayne Tower
2 South Biscayne Boulevard, Suite 3600
Miami, FL 33131

 

For CME information:
Melissa Vives, Associate CME Administrator
Email: MVives@researchtopractice.net
 

 

This program is supported by education grants from Genentech BioOncology, Roche Laboratories Inc and Sanofi-Aventis.

The audio tapes, compact discs, Internet content and accompanying printed material are protected by copyright. No part of this program may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, recording or utilizing any information storage and retrieval system, without written permission from the copyright owner.

The opinions expressed are those of the presenters and are not to be construed as those of the publisher or grantor. Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management.

Any procedures, medications or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information and comparison with recommendations of other authorities.

 

Table of Contents Top of Page

Home

Editor’s Note:
Is capecitabine the “AC” of
adjuvant therapy for colorectal cancer?
 
Leonard B Saltz, MD
- Select publications
 
Paulo M Hoff, MD
- Select publications
 
Michael J O’Connell, MD
- Select publications
 

Faculty Disclosures

A CME Audio Series
and Activity

Editor's office

 

Terms of Use and General Disclaimer.
Copyright © 2005 Research To Practice. All Rights Reserved.